Literature DB >> 21820190

Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study.

Liang-Yu Chen1, Liang-Kung Chen, Chih-Wei Chang, Shu-Chen Kuo, Lee-Fang Li, Yu-Jiun Chan, Fu-Der Wang.   

Abstract

S. aureus bacteremia (SAB) is a severe systemic illness, which is associated with high mortality and healthcare cost. It has been reported that older age per se is a poor prognostic factor of SAB, but little is known whether poor clinical outcomes is related to conservative attitudes of treating physicians. A retrospective cohort of 126 patients (mean age: 73.7 ± 13.6 years, 72.2% males) with community-onset SAB during 2004-2008 in a tertiary medical center in Taiwan was obtained for study. Demographic data, clinical characteristics, primary infectious focus, metastatic lesions, access to critical care units, performance of invasive procedures, Charlson comorbidity index (CCI) and in-hospital mortality for all study subjects were collected. The overall in-hospital mortality was 32.5%, which was not significantly different between adult and elderly groups. SAB of elderly patients was more likely to be primary than that of the adult patients (20.4% vs. 3.6%, p=0.043). Deep-seated abscess, osteomyelitis and metastatic lesion with central nervous system (CNS) involvement were more common infection foci in the adult patient group. Chronic obstructive pulmonary disease and cerebrovascular accident were more common underlying conditions of the elderly group. Chances of patients admitted to intensive care unit and employment of invasive procedures were not different between groups although elderly patients were supposed to be of a greater risk of mortality. In conclusion, the overall in-hospital mortality of community-onset SAB was 32.5%, which was not different between age groups. In general, older patients were of similar chance to receive critical care and invasive procedures except arterial line and non-tunneled central venous catheters. Further prospective investigation is needed to clarify whether physicians hold different attitudes to older patients with SAB and the differences in treatment attitude resulting in poorer clinical outcomes.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820190     DOI: 10.1016/j.archger.2011.07.003

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  4 in total

1.  Chronic osteomyelitis as a risk factor for development of rheumatoid arthritis: a nationwide, population-based, cohort study.

Authors:  Mao-Wang Ho; Chun-Hung Tseng; Jiunn-Horng Chen; Joung-Liang Lan; Chien-Chung Huang; Chih-Hsin Muo; Chung-Yi Hsu; Gregory J Tsay
Journal:  Clin Rheumatol       Date:  2015-07-23       Impact factor: 2.980

2.  Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.

Authors:  Fumihiro Mizokami; Masataka Shibasaki; Yasunori Yoshizue; Takeshi Noro; Tomohiro Mizuno; Katsunori Furuta
Journal:  Clin Interv Aging       Date:  2013-08-07       Impact factor: 4.458

3.  Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureus.

Authors:  Sunjun Yin; Gaoxiong Rao; Jin Wang; Liyang Luo; Gonghao He; Chengying Wang; Chaoyu Ma; Xiaoxing Luo; Zheng Hou; Guili Xu
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

4.  Selective in vivo and in vitro activities of 3,3'-4-nitrobenzylidene-bis-4-hydroxycoumarin against methicillin-resistant Staphylococcus aureus by inhibition of DNA polymerase III.

Authors:  Zheng Hou; Ying Zhou; Jing Li; Xinlei Zhang; Xin Shi; Xiaoyan Xue; Zhi Li; Bo Ma; Yukun Wang; Mingkai Li; Xiaoxing Luo
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.